000 01427 a2200421 4500
005 20250512230722.0
264 0 _c19840607
008 198406s 0 0 eng d
022 _a0065-2598
024 7 _a10.1007/978-1-4757-0390-0_93
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Jong, J W
245 0 0 _aThe Ca-antagonist nifedipine reduces purine nucleoside and oxypurine release from ischemic heart.
_h[electronic resource]
260 _bAdvances in experimental medicine and biology
_c1984
300 _a491-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenine Nucleotides
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aCoronary Circulation
650 0 4 _aCoronary Disease
_xmetabolism
650 0 4 _aHeart
_xdrug effects
650 0 4 _aHypoxanthine
650 0 4 _aHypoxanthines
_xmetabolism
650 0 4 _aIn Vitro Techniques
650 0 4 _aInosine
_xmetabolism
650 0 4 _aKinetics
650 0 4 _aMyocardium
_xmetabolism
650 0 4 _aNifedipine
_xpharmacology
650 0 4 _aPurine Nucleosides
_xmetabolism
650 0 4 _aRats
650 0 4 _aXanthine
650 0 4 _aXanthines
_xmetabolism
700 1 _aHarmsen, E
700 1 _ade Tombe, P P
700 1 _aKeijzer, E
773 0 _tAdvances in experimental medicine and biology
_gvol. 165 Pt B
_gp. 491-6
856 4 0 _uhttps://doi.org/10.1007/978-1-4757-0390-0_93
_zAvailable from publisher's website
999 _c6720234
_d6720234